What is Medline, Inc. 's interest income (expense), nonoperating?

Medline, Inc. (MDLN) reported interest income (expense), nonoperating of -$136M in Q1 2026.

How has Medline, Inc. 's interest income (expense), nonoperating changed year-over-year?

Medline, Inc. 's interest income (expense), nonoperating increased by 35.2% year-over-year, from -$210M to -$136M.

Medline, Inc. MDLN Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

CencoraCOR

-$140.46M-35.1%

Baxter InternationalBAX

——

SolventumSOLV

——

NovantaNOVT

——

MiMedx GroupMDXG

——

Acme UnitedACU

——

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$33.35B+7.3%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's interest income (expense), nonoperating?: Medline, Inc. (MDLN) reported interest income (expense), nonoperating of -$136M in Q1 2026.
How has Medline, Inc. 's interest income (expense), nonoperating changed year-over-year?: Medline, Inc. 's interest income (expense), nonoperating increased by 35.2% year-over-year, from -$210M to -$136M.